Workflow
Earnings estimate revision
icon
搜索文档
Gear Up for eBay (EBAY) Q1 Earnings: Wall Street Estimates for Key Metrics
ZACKS· 2026-04-28 22:16
核心财务预测 - 华尔街分析师预计eBay即将公布的季度每股收益为1.57美元,同比增长13.8% [1] - 预计季度营收将达到30.2亿美元,较去年同季度增长17% [1] - 过去30天内,市场对该公司季度每股收益的一致预期被向上修正了0.3% [2] 关键运营指标预测 - 分析师一致预测“总商品交易总额”将达到217.7亿美元,上年同期为187.5亿美元 [5] - 预计“活跃买家”数量将达到1.3522亿,上年同期为1.34亿 [5] - 预计“国际商品交易总额”将达到107.3亿美元,上年同期为96.9亿美元 [5] - 预计“美国商品交易总额”将达到110.5亿美元,上年同期为90.7亿美元 [6] - 分析师集体评估预测“变现率”为13.9%,上年同期为13.8% [6] 市场表现与分析师观点 - 过去一个月,eBay股价回报率为+14%,而同期Zacks S&P 500综合指数涨幅为+12.8% [6] - 目前,EBAY的Zacks评级为4级(卖出),表明其近期表现可能弱于整体市场 [6] - 盈利预测的修订是预测股票潜在市场反应的重要因素,大量实证研究显示盈利预测修正趋势与股票短期价格表现之间存在强关联 [3]
Wall Street Analysts See a 59.43% Upside in Docebo (DCBO): Can the Stock Really Move This High?
ZACKS· 2026-04-27 22:56
Docebo Inc. (DCBO) closed the last trading session at $18.24, gaining 9.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $29.08 indicates a 59.4% upside potential.The average comprises 12 short-term price targets ranging from a low of $24.00 to a high of $38.00, with a standard deviation of $4.65. While the lowest estimate indicates an increase of 31.6% from the current price lev ...
Wall Street's Insights Into Key Metrics Ahead of Stryker (SYK) Q1 Earnings
ZACKS· 2026-04-27 22:15
Wall Street analysts forecast that Stryker (SYK) will report quarterly earnings of $2.98 per share in its upcoming release, pointing to a year-over-year increase of 4.9%. It is anticipated that revenues will amount to $6.29 billion, exhibiting an increase of 7.3% compared to the year-ago quarter.The current level reflects an upward revision of 0.1% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their in ...
Organon (OGN) Soars 30.9%: Is Further Upside Left in the Stock?
ZACKS· 2026-04-27 21:30
Organon (OGN) shares rallied 30.9% in the last trading session to close at $11.26. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 42.2% gain over the past four weeks.Organon recorded a strong price rise on investors’ optimism following the announcement of its proposed acquisition by Sun Pharmaceutical Industries Limited (“Sun Pharma”). Under the agreement Sun Pharma will acquire all outstanding shares of Org ...